MBOT · Microbot Medical Inc
United States · RS rating 4 · As of 2026-10-14
| Price | 0.99 USD |
|---|---|
| 1-day change | -2.8% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 6 / 6 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 18 / 15 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +66.0% |
| Market cap (USD) | $146.4M |